Turk J Hematol. 2022; 39(1): 74-75 | DOI: 10.4274/tjh.galenos.2021.2021.0537

Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine

Tekin Guney¹, Ferda Can¹, Sema Akıncı¹, Özge Soyer Kösemehmetoğlu¹, İmdat Dilek^2
1University of Health Sciences Turkey, Ankara City Hospital, Clinic of Hematology, Ankara, Turkey
²Yıldırım Beyazıt University, Ankara City Hospital, Clinic of Hematology, Ankara, Turkey

Keywords: COVID-19 vaccine, Thrombotic thrombocytopenic purpura, BNT162b2

---

BNT162b2 Aşısı Sonrası Gelişen İmmün Aracılı Trombotik Trombositopenik Purpura

Tekin Guney¹, Ferda Can¹, Sema Akıncı¹, Özge Soyer Kösemehmetoğlu¹, İmdat Dilek^2
1University of Health Sciences Turkey, Ankara City Hospital, Clinic of Hematology, Ankara, Turkey
²Yıldırım Beyazıt University, Ankara City Hospital, Clinic of Hematology, Ankara, Turkey

Anahtar Kelimeler: COVİD-19 aşı, Trombotik trombositopenik purpura, BNT162b2

---

CITE